- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Ovarian Cysts in Canada
Total 366 results
-
AstraZenecaCompletedBRCA or HRR+ Mutated Ovarian Cancer PatientsItaly, Spain, Canada, Czechia, Poland, United Kingdom, Hungary, Bulgaria
-
AltaRexUnknownOvarian Cancer | Fallopian Tube Cancer | Primary Peritoneal Cavity CancerUnited States, Canada
-
Anna TinkerCompletedOvarian Cancer | Endometrial CancerCanada
-
AHS Cancer Control AlbertaCross Cancer InstituteCompletedSarcoma | Kidney Neoplasms | Testicular Neoplasms | Multiple Myeloma | Ovarian NeoplasmsCanada
-
AstraZenecaCompletedRelapsed Ovarian Cancer, BRCA Mutation, Platinum SensitivityUnited States, Canada
-
University College, LondonRecruitingOvarian CancerAustralia, United Kingdom, Canada, New Zealand
-
Shattuck Labs, Inc.Enrolling by invitationOvarian Cancer | Fallopian Tube Cancer | Epithelial Ovarian Cancer | Platinum-resistant Ovarian Cancer | Primary Peritoneal Carcinoma | Platinum-Resistant Fallopian Tube Carcinoma | Platinum-Resistant Primary Peritoneal CarcinomaUnited States, United Kingdom, Spain, Canada
-
Hoffmann-La RocheCompletedOvarian CancerBelgium, Spain, Canada, Russian Federation, United Kingdom, Hungary, Italy, Poland, Netherlands
-
SpringWorks Therapeutics, Inc.Active, not recruitingOvarian Cancer | Ovarian Granulosa Cell Tumor | Ovarian Granulosa-Stromal TumorUnited States, Canada, Poland
-
AstraZenecaCompletedOvarian Cancer, TNBC, SCLC, Other Solid TumoursUnited States, Canada
-
Gynecologic Oncology GroupNational Cancer Institute (NCI)TerminatedOvarian CancerUnited States, Canada
-
EMD SeronoSanofiCompletedOvarian CancerUnited States, Belgium, Canada, Australia, Spain, France, Poland
-
National Cancer Institute (NCI)Active, not recruitingSarcoma | Metastatic Renal Cell Carcinoma | Metastatic Melanoma | Recurrent Renal Cell Carcinoma | Recurrent Melanoma | Stage IV Renal Cell Cancer AJCC v8 | Metastatic Malignant Solid Neoplasm | Metastatic Colorectal Carcinoma | Stage IV Colorectal Cancer AJCC v8 | Clinical Stage IV Cutaneous Melanoma... and other conditionsUnited States, Canada
-
AstraZenecaParexel; Covance; Iqvia Pty Ltd; Theradex; Myriad Genetics, Inc.CompletedNon-Germline BRCA Mutated Ovarian CancerItaly, Spain, Sweden, Canada, Czechia, Poland, United Kingdom, Israel, Austria, Belgium, Switzerland, Netherlands, Bulgaria, Finland, Norway, Denmark, Slovenia, Portugal
-
Facet BiotechBiogenTerminatedPeritoneal Neoplasms | Ovarian CancerUnited States, Canada
-
AstraZenecaParexelWithdrawnOvarian CancerUnited States, Italy, Canada, Spain
-
University of TorontoActive, not recruitingCoronary Artery Disease | Melanoma | Diabetes Mellitus, Type 2 | Cancer, Breast | Cancer, Prostate | Cancer, Ovarian | Cancer, ColorectalCanada
-
ImunonActive, not recruitingFallopian Tube Cancer | Epithelial Ovarian Cancer | Primary Peritoneal CancerUnited States, Canada
-
AstraZenecaCompletedLymphoma | Breast Cancer | Pancreatic Cancer | Ovarian Cancer | Prostate Cancer | Malignant Solid TumorsUnited States, Canada
-
AbbVie (prior sponsor, Abbott)CompletedOvarian CancerUnited States, Australia, Canada, Hungary, Israel, New Zealand, Poland, United Kingdom
-
National Cancer Institute (NCI)CompletedRecurrent Ovarian Epithelial Cancer | Recurrent Primary Peritoneal Cavity Cancer | Recurrent Fallopian Tube CancerUnited States, Canada
-
Corcept TherapeuticsActive, not recruitingRecurrent Fallopian Tube Carcinoma | Recurrent Primary Peritoneal Carcinoma | Recurrent Ovarian CancerUnited States, Belgium, Canada, Italy, Spain
-
AstraZenecaEuropean Network of Gynaecological Oncological Trial Groups (ENGOT)CompletedEpithelial Ovarian CancerDenmark, France, Germany, Italy, Spain, Poland, Belgium, Canada, United Kingdom, Israel, Norway
-
GlaxoSmithKlineCompletedOvarian Cancer | Fallopian Tube Cancer | Peritoneal Cancer | Neoplasms, OvarianUnited States, Canada
-
Women's College HospitalUniversity Health Network, Toronto; Memorial Sloan Kettering Cancer Center; Sunnybrook... and other collaboratorsCompletedUterine Cervical Neoplasms | Uterine Neoplasms | Genital Neoplasms, Female | Ovarian Neoplasms | Sexual Dysfunctions, PsychologicalCanada, United States
-
Tesaro, Inc.Myriad Genetics, Inc.; Facing Our Risk of Cancer EmpoweredCompletedOvarian Neoplasms | Ovarian CancerUnited States, Canada
-
AstraZenecaMerck Sharp & Dohme LLC; Myriad Genetic Laboratories, Inc.CompletedRelapsed Ovarian Cancer, BRCA Mutation, Platinum SensitivityUnited States, Italy, Spain, Belgium, Poland, Canada, Korea, Republic of, Brazil, Czechia, Hungary, Israel, Argentina, Mexico
-
PharmaMarCompletedRelapsed Ovarian CancerSpain, France, Italy, Belgium, Germany
-
University Health Network, TorontoCompleted
-
Gynecologic Oncology GroupNational Cancer Institute (NCI)CompletedOvarian Cancer | Primary Peritoneal Cavity CancerUnited States, Canada
-
Gynecologic Oncology GroupNational Cancer Institute (NCI)CompletedOvarian Cancer | Primary Peritoneal Cavity CancerUnited States, Canada
-
pharmaand GmbHCompletedOvarian Cancer | Fallopian Tube Cancer | Epithelial Ovarian Cancer | Peritoneal Cancer | Other Solid Tumor | Metastatic Castration-Resistant Prostate CancerIsrael, Italy, Canada, Russian Federation, United Kingdom, Poland
-
NCIC Clinical Trials GroupCompletedOvarian CancerUnited States, Canada, United Kingdom
-
Sumitomo Pharma America, Inc.TerminatedFallopian Tube Cancer | Primary Peritoneal Cancer | Urothelial Carcinoma | Renal Cell Carcinoma (RCC) | Platinum-resistant Ovarian Cancer (PROC) | Serous Epithelial Ovarian CancerUnited States, Canada
-
Lawson Health Research InstituteActive, not recruitingCarcinosarcoma | Endometrioid Adenocarcinoma | Clear Cell Carcinoma | Serous Carcinoma | Dedifferentiated CarcinomaCanada
-
Astellas Pharma IncCompletedOvarian Cancer | Solid TumorsUnited States, United Kingdom, Australia, Canada, Switzerland, Czechia, Italy, Poland, Romania, Russian Federation
-
Translational Research in OncologyCompletedStudy of AMG 479 as Second Line Therapy in Patients With Recurrent Platinum-sensitive Ovarian CancerOvarian NeoplasmsUnited States, France, Ireland, Germany, Israel, Canada, Spain
-
MorphotekTerminatedOvarian CancerCanada, United States, Netherlands, Spain, Belgium, Australia
-
Hospices Civils de LyonCompletedOvarian CancerDenmark, Sweden, Finland, Italy, Canada, France
-
ImmunoGen, Inc.Gynecologic Oncology GroupCompletedOvarian Cancer | Fallopian Tube Cancer | Epithelial Ovarian Cancer | Primary Peritoneal CarcinomaUnited States, France, Canada, Spain, Switzerland, Belgium, Italy, United Kingdom, Ireland, Russian Federation, Bosnia and Herzegovina, Czechia, Serbia
-
Sutro Biopharma, Inc.GOG Foundation; European Network of Gynaecological Oncological Trial Groups... and other collaboratorsRecruitingOvarian Cancer | Fallopian Tube Cancer | Epithelial Ovarian Cancer | Platinum-resistant Ovarian Cancer | Primary Peritoneal CancerUnited States, Australia, Korea, Republic of, Israel, Singapore, Canada
-
AstraZenecaRecruitingAdv Solid Malig - H&N SCC, ATM Pro / Def NSCLC, Gastric, Breast and Ovarian CancerSpain, United States, Belgium, United Kingdom, France, Hungary, Canada, Korea, Republic of, Australia
-
AstraZenecaCompletedOvarian Neoplasms | Ovarian CancerBulgaria, Peru, Russian Federation, Romania, Norway, Canada, Denmark, Netherlands, Portugal, United Kingdom, France, Spain
-
Merck Sharp & Dohme LLCActive, not recruitingOvarian Carcinoma | High-grade Serous Ovarian CarcinomaKorea, Republic of, Spain, Poland, United States, Belgium, Canada, Chile, Israel, Italy, Singapore, Taiwan
-
Hoffmann-La RocheCompletedOvarian CancerFrance, Spain, Sweden, Hong Kong, Canada, Switzerland, Estonia, Greece, Russian Federation, Hungary, Austria, Bulgaria, Netherlands, Latvia, Italy, Slovenia, Turkey, Serbia, Israel, Argentina, Brazil, Slovakia, Lithuania, Poland, Portugal, Mexi... and more
-
SanofiRegeneron PharmaceuticalsCompletedOvarian Neoplasms | AscitesUnited States, Canada, Spain, India, Belgium, Austria, Hungary, Israel, United Kingdom
-
Mersana TherapeuticsGOG Foundation; European Network of Gynaecological Oncological Trial Groups...TerminatedUpifitamab Rilsodotin Maintenance in Platinum-Sensitive Recurrent Ovarian Cancer (UP-NEXT) (UP-NEXT)Fallopian Tube Cancer | Primary Peritoneal Cancer | High Grade Serous Ovarian CancerUnited States, Australia, Canada
-
AdaptimmuneGOG FoundationRecruitingOvarian CancerUnited States, Spain, France, Canada, United Kingdom
-
Incyte CorporationTerminatedOvarian Cancer | Genitourinary (GU) TumorsUkraine, United Kingdom, United States, Australia, Canada, Russian Federation
-
University Health Network, TorontoPrincess Margaret Hospital, Canada; Ontario Institute for Cancer Research; Terry...RecruitingMelanoma | Lymphoma | Kidney Cancer | Leukemia | Breast Cancer | Head and Neck Cancer | Colorectal Cancer | Lung Cancer | Solid Tumor | Prostate Cancer | Pancreas Cancer | Ovary CancerCanada